Abstract
Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have